RECANATI LEON 3
3 · Evogene Ltd. · Filed Mar 18, 2026
Insider Transaction Report
Form 3
Evogene Ltd.EVGN
RECANATI LEON
Director
Holdings
- 83,886
Ordinary shares
Stock Option (right to buy ordinary shares)
Exercise: $72.46From: 2020-06-11Exp: 2026-05-18→ Ordinary shares (250 underlying)Stock Option (right to buy ordinary shares)
Exercise: $54.32From: 2021-06-11Exp: 2027-05-16→ Ordinary shares (250 underlying)Stock Option (right to buy ordinary shares)
Exercise: $32.05From: 2022-06-11Exp: 2028-06-25→ Ordinary shares (250 underlying)Stock Option (right to buy ordinary shares)
Exercise: $17.68From: 2023-06-11Exp: 2029-07-30→ Ordinary shares (250 underlying)Stock Option (right to buy ordinary shares)
Exercise: $12.03From: 2024-06-11Exp: 2030-11-17→ Ordinary shares (250 underlying)Stock Option (right to buy ordinary shares)
Exercise: $39.32From: 2025-06-11Exp: 2031-06-11→ Ordinary shares (250 underlying)Stock Option (right to buy ordinary shares)
Exercise: $28.62From: 2022-08-10Exp: 2031-09-01→ Ordinary shares (1,800 underlying)Stock Option (right to buy ordinary shares)
Exercise: $10.50From: 2023-09-15Exp: 2032-09-15→ Ordinary shares (1,800 underlying)Stock Option (right to buy ordinary shares)
Exercise: $6.03From: 2024-05-11Exp: 2033-05-11→ Ordinary shares (1,800 underlying)Stock Option (right to buy ordinary shares)
Exercise: $7.16From: 2025-06-13Exp: 2034-06-13→ Ordinary shares (1,800 underlying)Stock Option (right to buy ordinary shares)
[F1]Exercise: $1.29Exp: 2035-08-18→ Ordinary shares (2,500 underlying)
Footnotes (1)
- [F1]The options reported in this row vest equally on a quarterly basis (25% per quarter) such that they will be fully vested on the one-year anniversary of the August 18, 2025 grant date.
Signature
/s/ Nitsan Deutsch, attorney-in-fact|2026-03-18